| answer text |
<p>The Department funds research through the National Institute for Health Research
(NIHR). NIHR welcomes funding applications for research into any aspect of human health,
including irritable bowel syndrome. It is not usual practice to ring-fence funds for
particular topics or conditions. Applications are subject to peer review and judged
in open competition, with awards being made on the basis of the importance of the
topic to patients and health and care services, value for money and scientific quality.</p><p>The
NIHR has four live projects on Irritable Bowel Syndrome totalling approximately £3.84
million:</p><p>- A randomised, placebo controlled trial to determine the efficacy
and mode of action of ondansetron in the treatment of irritable bowel syndrome with
diarrhoea;</p><p>- ACTIB (Assessing Cognitive Behavioural Therapy in Irritable Bowel):
A randomized controlled trial of clinical and cost effectiveness of therapist delivered
cognitive behavioural therapy and web-based self-management in irritable bowel syndrome;</p><p>-
Evaluation of faecal volatile organic compounds in the diagnosis of paediatric inflammatory
bowel disease; and</p><p>- Eluxadoline for treating irritable bowel syndrome with
diarrhoea.</p><p> </p><p>Further information on all NIHR projects can be found at
the following link:</p><p> </p><p><a href="http://www.journalslibrary.nihr.ac.uk/programmes/"
target="_blank">www.journalslibrary.nihr.ac.uk/programmes/</a></p>
|
|
